landmark NIH hypertension study will shake things up

January 2003

The surprising results from the landmark NIH hypertension study will shake things up.

The "modern" ACE inhibitors, calcium channel blockers, and beta-blockers won't be first choice for most patients anymore.

The huge ALLHAT study shows that a good old diuretic is often better.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

landmark NIH hypertension study will shake things up
Strattera, the first NON-stimulant drug approved for ADHD
Cardiology how recurrent atrial fibrillation patients are treated
Cardiology You'll be hearing a lot more this year about C-reactive protein
Cardiology statins decrease the effects of Plavix
some patients accidentally overdosing on their methotrexate
Infectious Diseases Copegus, a new ribavirin for hepatitis C
Infectious Diseases how to treat gonorrhea now that Wyeth is discontinuing cefixime (Suprax)
Infectious Diseases Pediarix, the first five-in-one vaccine for infants
Women's Health how to treat women with epilepsy
Women's Health whether to treat asymptomatic urinary tract infections in women with diabetes
Dermatology Aldara (imiquimod cream) to treat actinic keratoses
Dermatology latest treatments for wrinkles
Osteoporosis Forteo (teriparatide), human parathyroid hormone for treating osteoporosis
Is it legal for patients to import prescription drugs
Some patients are getting into trouble because they use the "float test" to see if their metered-dose inhaler is empty